Filtered By:
Cancer: Leukemia
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 28367 results found since Jan 2013.
A commentary on the optimal red blood cell transfusion threshold in acute leukemia patients
Blood Transfus. 2023 Sep 4. doi: 10.2450/BloodTransfus.594. Online ahead of print.NO ABSTRACTPMID:37677098 | DOI:10.2450/BloodTransfus.594
Source: Blood Transfusion - September 7, 2023 Category: Hematology Authors: Akua Asante Phuong-Lan Nguyen Neil Blumberg Source Type: research
Electromagnetic Radiation Exposure and Childhood Leukemia: Meta-Analysis and Systematic Review
CONCLUSIONS: The collective results of three meta-analyses, encompassing magnetic field strengths ranging from 0.1 μT to 2.38 μT, underscore a statistically significant association between the intensity of magnetic fields and the occurrence of childhood leukemia. However, one specific analysis concluded that no apparent relationship exists between exposure to 0.1 μT and an elevated risk of leukemia development in children.PMID:37678874
Source: Alternative Therapies in Health and Medicine - September 7, 2023 Category: Complementary Medicine Authors: Huaipeng Guo Lei Kang Weiwei Qin Yahong Li Source Type: research
A commentary on the optimal red blood cell transfusion threshold in acute leukemia patients
Blood Transfus. 2023 Sep 4. doi: 10.2450/BloodTransfus.594. Online ahead of print.NO ABSTRACTPMID:37677098 | DOI:10.2450/BloodTransfus.594
Source: Blood Transfusion - September 7, 2023 Category: Hematology Authors: Akua Asante Phuong-Lan Nguyen Neil Blumberg Source Type: research
Electromagnetic Radiation Exposure and Childhood Leukemia: Meta-Analysis and Systematic Review
CONCLUSIONS: The collective results of three meta-analyses, encompassing magnetic field strengths ranging from 0.1 μT to 2.38 μT, underscore a statistically significant association between the intensity of magnetic fields and the occurrence of childhood leukemia. However, one specific analysis concluded that no apparent relationship exists between exposure to 0.1 μT and an elevated risk of leukemia development in children.PMID:37678874
Source: Alternative Therapies in Health and Medicine - September 7, 2023 Category: Complementary Medicine Authors: Huaipeng Guo Lei Kang Weiwei Qin Yahong Li Source Type: research
Frequent, high density expression of surface CD38 as a potential therapeutic target in adult T-lineage acute lymphoblastic leukemia
Haematologica. 2023 Sep 7. doi: 10.3324/haematol.2023.283814. Online ahead of print.ABSTRACTNot available.PMID:37675513 | DOI:10.3324/haematol.2023.283814
Source: Haematologica - September 7, 2023 Category: Hematology Authors: Sebastian Koslowski Rainer Glauben Stefan Habringer Thomas Burmeister Ulrich Keller Monika Br üggemann Nicola G ökbuget Stefan Schwartz Source Type: research
Maximal benefit of minimal residual disease monitoring in pediatric acute myeloid leukemia
Haematologica. 2023 Sep 7. doi: 10.3324/haematol.2023.283765. Online ahead of print.ABSTRACTNot available.PMID:37675508 | DOI:10.3324/haematol.2023.283765
Source: Haematologica - September 7, 2023 Category: Hematology Authors: Henrik Hasle Kristian L øvvik Juul-Dam Source Type: research
Frequent, high density expression of surface CD38 as a potential therapeutic target in adult T-lineage acute lymphoblastic leukemia
Haematologica. 2023 Sep 7. doi: 10.3324/haematol.2023.283814. Online ahead of print.ABSTRACTNot available.PMID:37675513 | DOI:10.3324/haematol.2023.283814
Source: Haematologica - September 7, 2023 Category: Hematology Authors: Sebastian Koslowski Rainer Glauben Stefan Habringer Thomas Burmeister Ulrich Keller Monika Br üggemann Nicola G ökbuget Stefan Schwartz Source Type: research
Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation
Int J Lab Hematol. 2023 Sep 6. doi: 10.1111/ijlh.14167. Online ahead of print.NO ABSTRACTPMID:37674279 | DOI:10.1111/ijlh.14167
Source: International Journal of Laboratory Hematology - September 7, 2023 Category: Hematology Authors: Shuyu E Karen A Nahmod Sa A Wang C Cameron Yin Source Type: research
Frequent, high density expression of surface CD38 as a potential therapeutic target in adult T-lineage acute lymphoblastic leukemia
Haematologica. 2023 Sep 7. doi: 10.3324/haematol.2023.283814. Online ahead of print.ABSTRACTNot available.PMID:37675513 | DOI:10.3324/haematol.2023.283814
Source: Haematologica - September 7, 2023 Category: Hematology Authors: Sebastian Koslowski Rainer Glauben Stefan Habringer Thomas Burmeister Ulrich Keller Monika Br üggemann Nicola G ökbuget Stefan Schwartz Source Type: research
Maximal benefit of minimal residual disease monitoring in pediatric acute myeloid leukemia
Haematologica. 2023 Sep 7. doi: 10.3324/haematol.2023.283765. Online ahead of print.ABSTRACTNot available.PMID:37675508 | DOI:10.3324/haematol.2023.283765
Source: Haematologica - September 7, 2023 Category: Hematology Authors: Henrik Hasle Kristian L øvvik Juul-Dam Source Type: research
Generation of CHOPi-008-B, a euploid iPSC line from a patient with Trisomy 21 and a GATA1 mutation
Stem Cell Res. 2023 Sep 1;72:103198. doi: 10.1016/j.scr.2023.103198. Online ahead of print.ABSTRACTTransient myeloproliferative disorder (TMD) is a pre-leukemic condition that occurs only in neonates with Trisomy 21 (T21), and is attributed to a genetic interaction between the third copy of chromosome 21 (HSA21) and a mutation in the transcription factor GATA1 that results in a truncated protein (GATA1s). We generated a euploid iPSC line with a GATA1s mutation that is isogenic to a previously published pair of T21 lines with and without a GATA1 mutation. The line was characterized for pluripotency, differentiation potentia...
Source: Cell Research - September 7, 2023 Category: Cytology Authors: Kaoru Takasaki Sara S Kumar Alyssa Gagne Deborah L French Stella T Chou Source Type: research
Ozone attenuates chemotherapy-induced peripheral neuropathy via upregulating the AMPK-SOCS3 axis
CONCLUSIONS: In this study, we demonstrated that ozone could alleviate CIPN by upregulating the AMPK-SOCS3 axis to inhibit TF expression, which is a potential treatment for CIPN.PMID:37675733 | DOI:10.4103/jcrt.jcrt_912_23
Source: Cell Research - September 7, 2023 Category: Cytology Authors: Xiao-Tao Zhang Li-Juan Zong Ru-Meng Jia Xin-Miao Qin Shi-Rong Ruan Lin-Lin Lu Ping Wang Liang Hu Wen-Tao Liu Yang Yang Yan Li Source Type: research
Infectious complications among patients receiving ibrutinib for the treatment of hematological malignancies
CONCLUSION: Serious infection and IFI rates are high but similar to those previously described. Risk factors for serious infection included allo-HSCT and corticosteroid use. Targeted antimicrobial prophylaxis should be evaluated in prospective studies in patients on ibrutinib to reduce serious infections and IFI.PMID:37675967 | DOI:10.1093/ajhp/zxad210
Source: American Journal of Health-System Pharmacy : AJHP - September 7, 2023 Category: Drugs & Pharmacology Authors: Kenneth Tham Stacy Prelewicz Sara deHoll Deborah M Stephens Carlos A Gomez Source Type: research
Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation
Int J Lab Hematol. 2023 Sep 6. doi: 10.1111/ijlh.14167. Online ahead of print.NO ABSTRACTPMID:37674279 | DOI:10.1111/ijlh.14167
Source: International Journal of Laboratory Hematology - September 7, 2023 Category: Hematology Authors: Shuyu E Karen A Nahmod Sa A Wang C Cameron Yin Source Type: research
